Yes, azelaic acid 15% gel (Skinoren) is effective for treating rosacea.
Azelaic acid 15% gel is FDA-approved and clinically proven to reduce inflammatory lesions and erythema in papulopustular rosacea, making it a first-line topical treatment option for mild to moderate disease. 1
Mechanism of Action
Azelaic acid works by:
- Exerting anti-inflammatory activity on the cathelicidin pathway, which is upregulated in rosacea-affected skin 1
- Reducing reactive oxygen species 2
- Inhibiting pathologic expression of cathelicidin and the hyperactive protease activity that cleaves it into LL-37 3
Clinical Evidence
Pivotal FDA Approval Studies
Two large, 12-week, double-blind, randomized, vehicle-controlled trials with 664 subjects demonstrated clear efficacy 1, 4:
Study 1 (n=329):
- Inflammatory lesions decreased from 17.5 at baseline to 6.8 at 12 weeks (58% reduction)
- Vehicle group: 17.6 to 10.5 (40% reduction)
- 51% achieved marked improvement or complete remission
- 61% achieved therapeutic success (clear, minimal, or mild final result)
Study 2 (n=335):
- Inflammatory lesions decreased from 17.8 to 8.9 (51% reduction)
- Vehicle group: 18.5 to 12.1 (39% reduction)
- 46% achieved marked improvement or complete remission
- 62% achieved therapeutic success
Both studies showed statistically significant superiority over vehicle (P <0.0001 to P=0.0208) 4.
Erythema Improvement
Significantly higher proportions of patients experienced erythema improvement compared with vehicle:
- Study 1: 44% vs 29% (P=0.0017)
- Study 2: 46% vs 28% (P=0.0005) 4
Position in Treatment Algorithm
According to the 2017 ROSCO (Global Rosacea Consensus) panel guidelines, azelaic acid is recommended as a first-line topical treatment for mild to moderate inflammatory papules/pustules of rosacea 5. It appears alongside ivermectin and metronidazole as initial therapeutic options.
Comparative Effectiveness
While head-to-head studies are limited, available evidence suggests:
- Azelaic acid may produce quicker onset of clinical effect than metronidazole when combined with oral doxycycline 6
- In a 2016 network meta-analysis, ivermectin 1% cream was found more effective than available topical treatments including azelaic acid 15% gel 1
- However, azelaic acid remains a valid and effective first-line option with established efficacy 1, 5
Safety and Tolerability
- No serious treatment-related adverse events reported in pivotal trials 4
- Most common side effects are mild, transient stinging and burning, particularly in the first 3 weeks 1
- Does not induce epidermal permeability barrier impairment 6
- Proper skin care reduces likelihood of neurosensory adverse effects 6
- Minimal adverse reactions in real-world use 7, 3
Practical Application
Dosing: Apply twice daily to affected areas 4
Expected timeline:
- Significant improvement evident by 8-12 weeks 1, 4
- Continuous improvement over 15 weeks 2
- Effects may persist beyond active treatment phase 3
Common pitfall: Initial irritation (stinging, burning) in first 3 weeks may cause discontinuation. Counsel patients that this typically resolves with continued use 1.
Special Considerations
Important note: The FDA label provided 8 appears to be for an acne formulation, not the rosacea-specific product. The rosacea indication for azelaic acid 15% gel was FDA-approved in 2002 specifically for inflammatory lesions of rosacea 1.
Pregnancy: While not specifically addressed in the provided evidence, azelaic acid is generally considered safe, but always consult current prescribing information for pregnancy category and specific recommendations.